Ge, Junbo |
NCT03008083: Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation |
|
|
| Recruiting | 4 | 2446 | RoW | 3 months DAPT, Ticagrelor (180 mg/day) or Clopidogrel (75 mg/day), 12 months DAPT | Shanghai MicroPort Medical (Group) Co., Ltd. | Drug-Eluting Stents, Percutaneous Coronary Intervention | 12/20 | 10/22 | | |
CLEAN, NCT04665648: Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention |
|
|
| Recruiting | 4 | 1500 | RoW | Nicorandil, intraveous nicorandil, Placebo, intraveous palcebo | Fudan University | ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention | 08/24 | 12/24 | | |
NCT04135677: Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO |
|
|
| Recruiting | 4 | 826 | RoW | Rivaroxaban, new oral anticoagulation, DAPT, dual antiplatelet therapy | Shanghai Zhongshan Hospital | Left Atrial Appendage Thrombosis, Thrombi, Stroke | 10/24 | 10/24 | | |
TIGER, NCT04255602: A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients |
|
|
| Recruiting | 4 | 2120 | RoW | Ticagrelor 60mg, Ticagrelor 90mg | Shanghai Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Fudan University | Acute Coronary Syndrome, Coronary Stent Implantation | 12/24 | 12/24 | | |
| Recruiting | 4 | 2500 | Europe, RoW | Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care | CoreAalst BV, Insight Lifetech Co., Ltd. | Coronary Artery Disease, Acute Coronary Syndrome | 06/26 | 06/30 | | |
NCT05260411: A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia |
|
|
| Recruiting | 3 | 240 | RoW | AK102, Placebo | Akeso | Hyperlipidemia | 06/22 | 12/22 | | |
RECOVERII, NCT04571580: Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention |
|
|
| Terminated | 3 | 36 | RoW | Normal Saline, intracoronary normal saline, Reteplase Injection 9mg, intracoronary reteplase 9mg, Reteplase Injection 18mg, intracoronary reteplase 18mg | Ge Junbo | Acute ST-segment Elevation Myocardial Infarction | 01/23 | 01/23 | | |
| Active, not recruiting | 2 | 100 | RoW | Pirfenidone Oral Capsule, Placebo Oral Capsule | Shanghai Zhongshan Hospital, Beijing Continent Pharmaceutical Co, Ltd. | Myocardial Fibrosis | 05/24 | 06/24 | | |
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 539 | RoW | BuMA Supreme, BuMA™ | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 03/18 | 12/25 | | |
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 1000 | RoW | BuMA Supreme | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 05/19 | 12/25 | | |
NCT03466918: China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population |
|
|
| Active, not recruiting | N/A | 58 | RoW | SAPIEN 3 THV with the Commander delivery system | Edwards Lifesciences | Aortic Stenosis, Symptomatic Aortic Stenosis, Aortic Regurgitation | 07/19 | 09/25 | | |
| Not yet recruiting | N/A | 616 | NA | intravascular ultrasound (IVUS), coronary angiography | Shanghai Zhongshan Hospital | Coronary Artery Disease, Left Main Coronary Artery Disease | 09/21 | 09/23 | | |
NCT04582877: Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial |
|
|
| Completed | N/A | 300 | RoW | FFR measurement | Zurich Medical Inc. | Myocardial Ischemia | 11/23 | 04/24 | | |
NCT03716011: A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT |
|
|
| Not yet recruiting | N/A | 2700 | RoW | EXCROSSAL | JW Medical Systems Ltd | Coronary Artery Disease | 12/21 | 12/25 | | |
NCT04414878: VitaFlowâ„¢ II Transcatheter Aortic Valve System Pre-market Trial |
|
|
| Recruiting | N/A | 145 | RoW | VitaFlowâ„¢ II Transcatheter Aortic Valve System | Shanghai MicroPort CardioFlow Medtech Co., Ltd. | Aortic Stenosis | 01/22 | 01/27 | | |
NCT04575012: Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset |
|
|
| Not yet recruiting | N/A | 1200 | NA | Deferred invasive strategy, Early invasive strategy | Shanghai Zhongshan Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 12/22 | 12/25 | | |
NCT05391191: Safety and Feasibility of TRISKELE in Severe AS |
|
|
| Recruiting | N/A | 7 | RoW | MitrAssist TRISKELE® transcatheter aortic valve system | Shanghai Zhongshan Hospital | Aortic Valve Disease | 03/23 | 03/23 | | |
| Recruiting | N/A | 30 | RoW | FreeFlow percutaneous atrial septal shunt | Shanghai Zhongshan Hospital | Pulmonary Arterial Hypertension | 09/27 | 09/27 | | |
| Recruiting | N/A | 2132 | RoW | caFFR, Coronary Angiography-Derived Fractional Flow Reserve, FFR, Fractional Flow Reserve | Peking University First Hospital, Rainmed Ltd., Suzhou, China | Coronary Artery Disease, Coronary Stenosis, Myocardial Ischaemia, Coronary Circulation, Stable Angina Pectoris, Unstable Angina Pectoris, Asymptomatic Ischemia, Acute Myocardial Infarction, Percutaneous Coronary Intervention | 12/23 | 12/25 | | |
NCT03714802: Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases |
|
|
| Recruiting | N/A | 100 | RoW | Szabo T-Stenting Technique, T-Stenting Technique | Shanghai Zhongshan Hospital | Coronary Artery Disease | 12/23 | 12/24 | | |
| Recruiting | N/A | 200 | RoW | Oral apixaban | Shanghai Zhongshan Hospital | Evaluate the Safety and Efficacy of Apixaban | 12/23 | 12/24 | | |
NCT06110988: A Clinical Study for the Pan-vascular Interventional Robotic System |
|
|
| Not yet recruiting | N/A | 5 | RoW | Pan-vascular interventional robotic system | Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. | Percutaneous Coronary Intervention, Pan-vascular Interventional Robotic System | 09/24 | 09/24 | | |
NCT06213714: The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial |
|
|
| Not yet recruiting | N/A | 12 | NA | 5G Tele-Robotic-Assisted PCI, VRS100 Robotic Console System | Yan'an Affiliated Hospital of Kunming Medical University, Shanghai Zhongshan Hospital, Kunming Chenggong District People's Hospital | Coronary Artery Disease, Myocardial Ischemia, Cardiovascular Diseases, Coronary Disease, Arteriosclerosis | 06/24 | 09/24 | | |
NCT03736226: A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China |
|
|
| Active, not recruiting | N/A | 2000 | RoW | SYNERGYTM Stent System | Boston Scientific Corporation | Cardiovascular Diseases | 08/24 | 03/28 | | |
NCT06502938: A Clinical Trial Evaluating the Pan-vascular Interventional Robotic System for Panvascularization Interventional Surgery |
|
|
| Not yet recruiting | N/A | 159 | RoW | Pan-vascular interventional robotic system, Traditional artificial percutaneous coronary intervention | Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. | Percutaneous Coronary Intervention | 07/25 | 12/25 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
NCT06032572: Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) |
|
|
| Not yet recruiting | N/A | 204 | RoW | VRS100 robotic-assisted PCI, Manual PCI | Shenzhen Raysight Intelligent Medical Technology Co., Ltd., Shanghai Zhongshan Hospital, West China Hospital, Shenzhen People's Hospital | Coronary Artery Disease, Cardiovascular Diseases, Coronary Disease, Myocardial Ischemia, Arteriosclerosis, Vascular Disease Occlusive | 08/24 | 08/24 | | |
| Not yet recruiting | N/A | 100 | RoW | computed tomography myocardial perfusion, Invasive Coronary Angiography | Shanghai Zhongshan Hospital | Non-ST Elevation Myocardial Infarction | 02/25 | 02/26 | | |
VITAL, NCT05813704: Coronary Crossing System in Patients With Coronary Chronic Total Occlusions |
|
|
| Recruiting | N/A | 156 | RoW | Coronary Crossing System of Shanghai MicroPort Rhythm | Shanghai MicroPort Rhythm MedTech Co., Ltd., Shanghai Zhongshan Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Shanghai Baoshan District Wusong Central Hospital, Wuhan Union Hospital, China, The First Affiliated Hospital of Nanchang University, First Affiliated Hospital Xi'an Jiaotong University, First Affiliated Hospital of Wenzhou Medical University, Tianjin First Central Hospital, The Affiliated Hospital Of Southwest Medical University, Hebei General Hospital, West China Hospital, First Affiliated Hospital of Army Medical University, PLA, Lanzhou University First Hospital, Nanfang Hospital, Southern Medical University, The Second Affiliated Hospital of Dalian Medical University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Chronic Total Occlusion of Coronary Artery | 04/25 | 05/25 | | |
CONFIDENT, NCT05857904: Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain |
|
|
| Not yet recruiting | N/A | 4648 | RoW | CT-FFR, QFR | Shanghai Zhongshan Hospital | Angina, Stable, Coronary Artery Disease | 05/25 | 05/28 | | |
NCT05947448: Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study |
|
|
| Recruiting | N/A | 1215 | RoW | Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine Maleate Table | Hasten Biopharmaceutical Co., Ltd. | Essential Hypertension | 06/25 | 12/25 | | |
| Recruiting | N/A | 5000 | RoW | Coronary CT angiography | Shanghai Zhongshan Hospital | Coronary Artery Disease | 12/25 | 12/30 | | |
NCT05194423: THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein |
|
|
| Recruiting | N/A | 150 | RoW | Tricuspid Valve Replacement System via jugular vein | Changhai Hospital, Shanghai Zhongshan Hospital, Fu Wai Hospital, Beijing, China, Beijing Anzhen Hospital, Wuhan Union Hospital, China, West China Hospital, Xijing Hospital, Guangdong Provincial People's Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University | Tricuspid Valve Regurgitation | 03/27 | 03/27 | | |
| Recruiting | N/A | 10000 | RoW | | Seung-Jung Park, CardioVascular Research Foundation, Korea | Coronary Artery Disease | 12/32 | 12/33 | | |
| Not yet recruiting | N/A | 271 | RoW | Angiography-drived Index of Microcirculatory Resistance, Angio-IMR, CaIMR | Shanghai Zhongshan Hospital, Shanghai 10th People's Hospital | Coronary Microvascular Dysfunction, Myocardial Ischemia | 05/21 | 10/21 | | |
CHART-OPTIMIZE, NCT05125107: PrOgnostic imPlicaTIons of 2-diMensIonal Patterns for Residual Disease After Stenting CharacteriZEd by Quantitative Flow Ratio Pullback Curve Analysis |
|
|
| Not yet recruiting | N/A | 1607 | NA | Quantitative Flow Ratio derived PPG and dQFR/ds | Shanghai Zhongshan Hospital, Chinese Academy of Medical Sciences, Fuwai Hospital | Coronary Artery Disease | 12/21 | 03/22 | | |
CHART-ORIGIN, NCT05104580: PrOgnostic Implications of PRe-stent Pullback Pressure GradIent and Post-stent Quantitative Flow Ratio in Patients UnderGoing Percutaneous Coronary INtervention |
|
|
| Not yet recruiting | N/A | 1395 | NA | Quantitative Flow Ratio derived PPG | Shanghai Zhongshan Hospital, Chinese Academy of Medical Sciences, Fuwai Hospital | Coronary Artery Disease | 01/22 | 03/22 | | |
| Recruiting | N/A | 378 | RoW | Coronary CTA | Shanghai Zhongshan Hospital | Coronary Artery Disease | 04/22 | 05/22 | | |
| Recruiting | N/A | 329 | RoW | Percutaneous coronary intervention | Shanghai Zhongshan Hospital | Coronary Artery Disease | 08/22 | 10/22 | | |
NCT04518826: A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES |
|
|
| Not yet recruiting | N/A | 420 | NA | fractional flow reserve | Shanghai Zhongshan Hospital | In Stent Restenosis, Drug Eluting Stent, Coronary Artery Disease | 10/22 | 10/24 | | |
| Recruiting | N/A | 300 | RoW | CCTA and 18F-FDG-PET/CT | Shanghai Zhongshan Hospital | Coronary Artery Disease | 10/22 | 12/22 | | |
Wang, Zhen Jun |
NCT04834531: Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng) |
|
|
| Not yet recruiting | 4 | 324 | RoW | Zhuli capsule, Placebo, Standard medical treatment | Zhong Wang | Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | 10/23 | 10/23 | | |
BHV3000-318, NCT05371652: A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants |
|
|
| Completed | 3 | 241 | RoW | Rimegepant 75mg Orally Disintegrating Tablets (ODT) | Pfizer, Bioshin (Shanghai) Consulting Services Co., Ltd | Acute Migraine | 02/24 | 02/24 | | |
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel |
|
|
| Completed | 3 | 571 | Europe, Canada, US, RoW | NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel | NovoCure Ltd. | Pancreas Adenocarcinoma | 10/24 | 10/24 | | |
NCT06295432: A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21) |
|
|
| Recruiting | 2 | 90 | RoW | DZD9008+AZD4205, Inapplicable | Dizal Pharmaceuticals | Non-small Cell Lung Cancer | 06/25 | 06/25 | | |
NCT03934567: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma |
|
|
| Recruiting | 2 | 96 | RoW | Abexinostat | Xynomic Pharmaceuticals, Inc. | Lymphoma, Follicular | 02/24 | 09/24 | | |
NCT03936153: Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) |
|
|
| Recruiting | 2 | 170 | RoW | abexinostat | Xynomic Pharmaceuticals, Inc. | Diffuse Large B-cell Lymphoma (DLBCL) | 12/24 | 05/25 | | |
NCT04539951: Pragmatic Trial of Obsessive-compulsive Disorder |
|
|
| Recruiting | 2 | 1600 | RoW | Sertraline 200 milligram(mg), Sertraline 300 milligram(mg), Fluvoxamine, Venlafaxine, Augment with Memantine, Augment with Aripiprazole | Shanghai Mental Health Center, The first specialized hospital of harbin, Guizhou Provincial People's Hospital, First Affiliated Hospital of Jinan University, West China Hospital, Suzhou Psychiatric Hospital, Nanjing Medical University, Wuhan Mental Health Centre, Seventh People's Hospital of Hangzhou, The First Affiliated Hospital of Kunming Medical College, General Hospital of Ningxia Medical University, The First Affiliated Hospital of Nanchang University, The Second Affiliated Hospital of Xinxiang Medical University | Obsessive-Compulsive Disorder | 06/24 | 12/24 | | |
NCT05956587: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors |
|
|
| Recruiting | 2 | 121 | RoW | BL-B01D1, SI-B003 | Sichuan Baili Pharmaceutical Co., Ltd., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma | 11/25 | 11/25 | | |
NCT04258462: Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors |
|
|
| Recruiting | 2 | 100 | US | Hyperpolarized Carbon C 13 Pyruvate, Hyperpolarized 13C-Pyruvate, Hyperpolarized Pyruvate (13C), Magnetic Resonance Imaging, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MRI, MRI Scan, Nuclear Magnetic Resonance Imaging, Hyperpolarized 13C,15N2-urea, HP 13C, 15N2 | Zhen Wang, MD, American Cancer Society, Inc., National Cancer Institute (NCI) | Benign Kidney Neoplasm, Kidney Neoplasm, Renal Cell Cancer | 12/26 | 12/26 | | |
| Recruiting | 1/2 | 380 | RoW | PM8002 | Biotheus Inc. | Malignant Neoplasm | 11/25 | 11/25 | | |
NCT04390737: Evaluate the Safety and Clinical Activity of HH2853 |
|
|
| Recruiting | 1/2 | 254 | US, RoW | HH2853 Tablets | Haihe Biopharma Co., Ltd. | FL Lymphoma, Epithelioid Sarcoma, Peripheral T Cell Lymphoma, Advanced Solid Tumor | 12/25 | 12/25 | | |
GFH009X2101, NCT04588922: Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies |
|
|
| Recruiting | 1/2 | 160 | US, RoW | SLS009, GFH009, venetoclax, Venclexta, azacitidine, Vidaza, azacytidine | Sellas Life Sciences Group, Sellas Life Sciences Group | Hematologic Malignancies | 06/25 | 12/25 | | |
NCT06139536: Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients |
|
|
| Recruiting | 1 | 210 | RoW | BAT4706 Injection, Fc-glycosylated recombinant fully humanized anti-CTLA-4 monoclonal antibody injection, BAT1308 Injection, Recombinant humanized anti PD-1 monoclonal antibody injection | Bio-Thera Solutions | Advanced Solid Tumor | 12/25 | 02/26 | | |
NCT05982080: A Study to Investigate FP002 in Subjects With Advanced Malignancies |
|
|
| Recruiting | 1 | 27 | RoW | FP002 Injection | Guangdong Fapon Biopharma Inc. | Advanced Solid Tumor | 04/25 | 07/26 | | |
NCT04033484: Pelvic Floor Reconstruction Using Biological Mesh With Negative Pressure Wound Therapy Following ELAPE |
|
|
| Recruiting | N/A | 66 | RoW | Negative Pressure Wound Therapy | Beijing Chao Yang Hospital | Perineal Wound Complications After ELAPE | 07/21 | 07/21 | | |
NCT04039646: ERAS in Patients With Perforated Peptic Ulcer Disease Who Underwent Laparoscopic Repair |
|
|
| Recruiting | N/A | 40 | RoW | ERAS treatment | Beijing Chao Yang Hospital | Hospital Stay, Hospital Cost | 12/21 | 03/22 | | |
LOCAL, NCT03046316: Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy |
|
|
| Recruiting | N/A | 60 | RoW | local consolidative treatment | Guangdong Association of Clinical Trials | Lung Neoplasms | 07/22 | 07/26 | | |
NCT04086446: Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD) |
|
|
| Recruiting | N/A | 60 | RoW | high-definition transcranial direct current stimulation, Sham tDCS | Shanghai Mental Health Center | Obsessive-Compulsive Disorder | 08/22 | 12/22 | | |
NCT04534504: Sleeve Gastrectomy With Uncut Jejunal Bypass (SG-uncut JJB) Verus Sleeve Gastrectomy in Obese Patients |
|
|
| Recruiting | N/A | 60 | RoW | SG-JJB | Zhen Jun Wang | Excessive Weight Loss, Total Weight Loss, Sleeve Gastrectomy, Jejunojejunal Bypass, Uncut | 08/22 | 08/22 | | |
NCT03649685: Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive Disorder |
|
|
| Recruiting | N/A | 120 | RoW | Continuous theta burst stimulation (cTBS), shame rTMS | Shanghai Mental Health Center, RenJi Hospital, Shanghai 10th People's Hospital | Obsessive-Compulsive Disorder | 12/22 | 04/23 | | |
NCT04527302: Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Obsessive-Compulsive Disorder (OCD) |
|
|
| Recruiting | N/A | 60 | RoW | ERP combined with high-definition active tDCS, ERP combined with sham tDCS | Shanghai Mental Health Center | Obsessive-Compulsive Disorder | 06/24 | 08/24 | | |
NCT05445999: A Preliminary Study of Model-driven Individualized Transcranial Electrical Stimulation for Insomnia |
|
|
| Recruiting | N/A | 12 | RoW | High-Definition transcranial electrical stimulation | Shanghai Mental Health Center | Insomnia | 12/24 | 02/25 | | |
NCT04426773: Electroencephalography (EEG) Predictors of Transcranial Direct Current Stimulation (tDCS) in Obsessive-Compulsive Disorder (OCD) |
|
|
| Recruiting | N/A | 30 | RoW | High-Definition transcranial direct current stimulation | Shanghai Mental Health Center | Obsessive-Compulsive Disorder | 04/23 | 12/23 | | |
NCT06085768: A Preliminary Study on the Intervention Effect of Virtual Reality Exposure Therapy on Fear of Flying |
|
|
| Recruiting | N/A | 64 | RoW | VRE intervention | Shanghai Mental Health Center | Fear of Flying, Virtual Reality Exposure Therapy | 11/23 | 11/23 | | |
NCT06105970: Chinese Community Sample of Hierarchical Model of Psychopathology |
|
|
| Recruiting | N/A | 4000 | RoW | No intervention | Shanghai Mental Health Center | Mental Health Issue, Adverse Childhood Experience | 11/23 | 11/27 | | |
NACSOC, NCT02972541: Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer |
|
|
| Recruiting | N/A | 248 | RoW | Stenting with neoadjuvant chemotherapy, Stenting with immediate Surgery | Beijing Chao Yang Hospital | Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction | 12/23 | 12/23 | | |
NACSOC-02, NCT05202314: Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer |
|
|
| Recruiting | N/A | 20 | RoW | Immunotherapy (Camrelizumab), Chemotheray (CAPOX or mFOLFOX6) | Beijing Chao Yang Hospital | Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction, Immunotherapy | 12/23 | 12/26 | | |
| Recruiting | N/A | 66 | RoW | reestablishment of the acute angle of His, sleeve gastrectomy | Zhen Jun Wang | Gastroesophageal Reflux Disease, Excessive Weight Loss, Total Weight Loss, Sleeve Gastrectomy, Angle of His | 12/23 | 12/25 | | |
NCT04534907: The Effect of Immersive Virtual Reality Treatment With Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder |
|
|
| Not yet recruiting | N/A | 30 | RoW | The combination of exposure and response prevention (ERP) and VR, Traditional ERP | Shanghai Mental Health Center | Obsessive-Compulsive Disorder, Virtual Reality | 12/23 | 12/24 | | |
NCT06331923: Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes |
|
|
| Recruiting | N/A | 10168 | RoW | Continuous glucose monitoring (CGM) device | Beijing Tsinghua Chang Gung Hospital, Peking University International Hospital, Wang Jing Hospital, ZhuHai Hospital, Beijing Hospital, Siyang County Hospital of Traditional Chinese Medicine, Second Hospital of Shanxi Medical University, Henan Provincial Chest Hospital, Fuzhou First Hospital, Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital, The First Affiliated Hospital of Anhui University of Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Mindong Hospital of Ningde, The Fifth Hospital of Xiamen, People's Hospital of Ningxia Hui Autonomous Region, The First People's Hospital of Changzhou, The Fifth hospital of Deyang, Suzhou Municipal Hospital, Tang-Du Hospital, Yiyang Central Hospital, First Affiliated Hospital of Xinjiang Medical University, Peng Ding Shan Shi Zhong Yi Yi Yuan, Yueyang Central Hospital, The First People's Hospital of Lianyungang, Haimen District Traditional Chinese Medicine Hospital, The 910th Hospital, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Beijing Tiantan Hospital, Affiliated Hospital of Jiangsu University, Liaocheng People's Hospital, Beijing Chao Yang Hospital, Jilin City Hospital of Chemical Industry, Creen Hospital-465, Wuhan Central Hospital, Air Force Military Medical University, China, Shanghai Tong Ren Hospital, Beijing Anzhen Hospital, Emergency General Hospital, Beijing Tongren Hospital, Civil Aviation General Hospital, Peking University Shougang Hospital, The First Affiliated Hospital of Anhui Medical University, Chinese PLA Central Hospital | Comprehensive Complication Index | 10/25 | 12/25 | | |
NCT06717165: Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy with Transcranial Alternating Current Stimulation for Obsessive-Compulsive Disorder (OCD) |
|
|
| Enrolling by invitation | N/A | 120 | RoW | ERP combined with high-definition active tACS, ERP combined with sham tACS | Shanghai Mental Health Center | Obsessive Compulsive Disorder (OCD) | 10/27 | 12/27 | | |
NCT04967560: The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD |
|
|
| Recruiting | N/A | 64 | RoW | deep brain stimulation | Shanghai Mental Health Center, West China Hospital, Huashan Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Brain Hospital, First Affiliated Hospital of Kunming Medical University, Changhai Hospital, SceneRay Corporation, Limited | Obsessive-Compulsive Disorder | 07/24 | 10/24 | | |
NCT06754319: Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis |
|
|
| Enrolling by invitation | N/A | 125 | RoW | | Shanghai Mental Health Center | Obsessive-Compulsive Disorder, Tic Disorder | 12/27 | 12/27 | | |
NCT06692114: Efficacy and Influencing Factors of Deep Transcranial Magnetic Stimulation in the Treatment of OCD |
|
|
| Recruiting | N/A | 86 | RoW | Deep Transcranial Magnetic Stimulation, DTMS active, Deep Transcranial Magnetic Stimulation, DTMS sham | Zhen Wang | Obsessive-Compulsive Disorder | 06/27 | 09/27 | | |
NCT06600906: Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
|
|
| Recruiting | N/A | 70 | US | Hyperpolarized 13C-Pyruvate, HP 13C, Computed tomography (CT), CT, Magnetic Resonance Imaging (MRI), MRI | University of California, San Francisco, National Cancer Institute (NCI) | Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | 08/30 | 09/32 | | |
NCT06671457: Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders |
|
|
| Recruiting | N/A | 40 | RoW | Active transcranial direct current stimulation, Sham transcranial direct current stimulation | Zhen Wang | Insomnia | 12/25 | 04/26 | | |
NCT06112067: Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders |
|
|
| Recruiting | N/A | 18 | RoW | deep brain stimulation | Shanghai Mental Health Center, SceneRay Corporation, Limited, Huashan Hospital, Shanghai 6th People's Hospital, Changhai Hospital | Deep Brain Stimulation | 12/24 | 12/24 | | |
NCT02395367: Prospective, Observational, Real-world Oral Malignant Tumors Study |
|
|
| Recruiting | N/A | 30000 | RoW | resection, adjuvant radiotherapy, neoadjuvant chemotherapy or adjuvant chemotherapy | Beijing Stomatological Hospital, Peking University Hospital of Stomatology, Beijing Shijitan Hospital of Capital Medical University, Beijing Friendship Hospital, The First Affiliated Hospital of Zhengzhou University, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Beijing Chao Yang Hospital | Head and Neck Neoplasms, Quality of Life, Postoperative Complications | 03/25 | 03/25 | | |
| Recruiting | N/A | 100000 | RoW | | Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital | Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia | 01/38 | 01/38 | | |
| Recruiting | N/A | 40000 | RoW | | Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital | Alzheimer Disease, Familial Alzheimer Disease (FAD) | 01/38 | 01/38 | | |